AMEUF (Anteris Technologies) Buyback Yield % : -109.82 (As of Apr. 10, 2025)

View and export this data going back to 2006. Start your Free Trial

What is Anteris Technologies Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Anteris Technologies's current buyback yield was -109.82%.

Anteris Technologies Buyback Yield % Historical Data

The historical data trend for Anteris Technologies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Buyback Yield % Chart

Anteris Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-4.55

-24.62

-10.62

-21.70

-68.43

Anteris Technologies Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															-10.92	-10.20	-22.35	-19.25	-61.48

Competitive Comparison of Anteris Technologies's Buyback Yield %

For the Medical Devices subindustry, Anteris Technologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anteris Technologies's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Anteris Technologies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Anteris Technologies's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	115.727)	/	169.12
	=	-68.43%

Anteris Technologies's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	115.727)		/	169.12
	=	-68.43%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Anteris Technologies Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (OTCPK:AMEUF) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

AVR:Australia

Address

9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow.